Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS)

Historical Holders from Q2 2021 to Q3 2025

Type / Class
Equity / American Depositary Shares, each representing one ordinary share
Symbol
BRNS on Nasdaq
Shares outstanding
40,291,821
Price per share
$1.25
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
9,172,174
Holdings value
$10,350,135
% of all portfolios
0%
Share change
-137,487
Value change
-$134,697
Average buys %
+0%
Average sells %
-0%
Number of holders
15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cawood Frank Wayne 8.4% $2,369,159 3,384,513 Frank W. Cawood 31 Dec 2024
As of 30 Sep 2025, Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) has 15 institutional shareholders filing 13F forms. They hold 9,172,174 shares of 40,291,821 outstanding shares (23%) .

Top 18 institutional shareholders own 23% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
M&G PLC 13% 5,197,349 0% 0.03% $5,197,349
Alphabet Inc. 3.8% 1,513,644 0% 0.08% $1,892,055
HSG Holding Ltd 3.5% 1,420,473 0% 0.1% $1,960,253
DC Funds, LP 1.6% 642,204 0% 26% $802,755
Johns Hopkins University 0.3% 122,237 0% 0.01% $152,796
Baird Financial Group, Inc. 0.27% 107,461 -44% 0% $134,326
RENAISSANCE TECHNOLOGIES LLC 0.16% 66,300 +83% 0% $82,875
HighTower Advisors, LLC 0.09% 37,450 0% 0% $46,813
HRT FINANCIAL LP 0.05% 20,152 0% $25,000
Janney Montgomery Scott LLC 0.04% 15,373 0% 0% $19,000
XTX Topco Ltd 0.03% 13,007 0% $16,259
GEODE CAPITAL MANAGEMENT, LLC 0.03% 11,568 0% 0% $14,460
MORGAN STANLEY 0.01% 4,942 +1.9% 0% $6,177
UBS Group AG 0% 13 0% $16
SBI Securities Co., Ltd. 0% 1 0% $1
CITADEL ADVISORS LLC 0% 0 -100% $0
New England Capital Financial Advisors LLC 0% 0 -100% $0
GILEAD SCIENCES, INC. 0% 0 -100% $0

Institutional Holders of Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 9,172,174 $10,350,135 -$134,697 $1.25 15
2025 Q2 9,309,661 $9,021,053 -$163,259 $0.9301 14
2025 Q1 9,485,402 $9,148,082 -$234,186 $0.9727 14
2024 Q4 9,717,331 $10,336,336 -$702,886 $1.21 16
2024 Q3 9,686,533 $10,740,001 -$279,453 $1.19 19
2024 Q2 9,914,647 $11,759,119 +$303,322 $1.40 18
2024 Q1 9,698,209 $21,348,890 -$38,841 $2.38 15
2023 Q4 9,718,135 $36,531,700 +$59,231 $3.69 15
2023 Q3 9,706,658 $29,525,600 -$281,231 $3.09 16
2023 Q2 9,847,143 $19,972,820 -$752,583 $2.06 15
2023 Q1 10,208,776 $21,620,956 -$48,613 $2.24 13
2022 Q4 10,228,507 $22,244,733 +$312,158 $2.35 15
2022 Q3 10,095,963 $31,249,000 +$10,999,320 $3.20 11
2022 Q2 6,298,127 $27,536,000 +$7,434,933 $4.45 12
2022 Q1 4,627,371 $23,843,000 -$1,912,066 $5.20 10
2021 Q4 4,901,592 $54,334,000 -$2,208,195 $11.11 14
2021 Q3 4,927,049 $77,592,000 -$4,976,202 $15.74 15
2021 Q2 4,629,642 $76,791,000 +$66,015,127 $16.78 19